Thinking outside the embryo
Since 2001, when a federal funding freeze crippled research into the use of human embryonic stem cells to treat a host of congenital and degenerative conditions, molecular biologists have searched for a viable alternative. Now, they may have found a way. By reprogramming adult skin cells, researchers have produced stem cells that bypass the political and ethical stumbling blocks. But all is not perfect. In recent studies, the cells produced tumors in mice. Guest: Dr. George Daley, associate director of the Stem Cell Program, Children’s Hospital Boston.
The World is an independent newsroom. We’re not funded by billionaires; instead, we rely on readers and listeners like you. As a listener, you’re a crucial part of our team and our global community. If you’ve been thinking about making a donation, this is the best time to do it. Your support is vital to running our nonprofit newsroom, and we can’t do this work without you. All donations between now and June 30 will be matched 2:1. Will you help keep our newsroom on strong footing by giving to The World?